Acesso livre
Acesso livre

Ginecologia/Obstetrícia

Diretriz atualizada | Momento da cirurgia eletiva e avaliação de risco após infecção por SARS-CoV-2 – “Mantemos a orientação de que os pacientes devem evitar cirurgias eletivas dentro de 7 semanas da infecção, a menos que os benefícios superem o risco de aguardar por tal período.”

1 Mar, 2022 | 15:38h

Timing of elective surgery and risk assessment after SARS-CoV-2 infection: an update – Anaesthesia

Conteúdos relacionados:

Perioperative cardiovascular considerations prior to elective noncardiac surgery in patients with a history of Covid-19.

Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk

BJS commission on surgery and perioperative care post-COVID-19.

The risk of postoperative complications following major elective surgery in active or resolved COVID-19 in the United States – Major, elective surgery 0–4 weeks after Covid-19 is associated with greatly increased risk of postoperative complications; surgery performed 4–8 weeks after infection is still associated with an increased risk of pneumonia.

ASA Guidance: Preoperative testing for COVID-19 is essential, regardless of vaccination.

Position statement: Perioperative management of post-COVID-19 surgical patients.

Cohort study: Postoperative in-hospital mortality of patients with COVID-19 infection was more than double that in patients without COVID-19


Estudo randomizado | Indicação de exercício precoce e com supervisão após cirurgia de câncer de mama melhora a função do ombro e a qualidade de vida relacionada a saúde.

1 Mar, 2022 | 15:30h

Resumo: Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT – Health Technology Assessment

Relatório completo: Exercise to prevent shoulder problems after breast cancer surgery: the PROSPER RCT – Health Technology Assessment

Conteúdo relacionado: RCT: Prophylactic Use of Compression Sleeves Reduces the Incidence of Arm Swelling in Women at High Risk of Breast Cancer–Related Lymphedema.


M-A | Desfechos materno-fetais após uso de agentes biológicos durante a concepção e a gestação.

25 Fev, 2022 | 14:03h

Fetal and maternal outcomes after maternal biologic use during conception and pregnancy: a systematic review and meta-analysis – BJOG


Pancreatite aguda na gestação: metanálise de desfechos materno-fetais.

25 Fev, 2022 | 14:02h

Acute pancreatitis in pregnancy: meta-analysis of maternal and fetal outcomes – British Journal of Surgery

 

Comentário no Twitter

 


Mortalidade por síndrome do Zika congênita – Estudo de coorte nacional no Brasil.

24 Fev, 2022 | 15:43h

Mortality from Congenital Zika Syndrome — Nationwide Cohort Study in Brazil – New England Journal of Medicine


Revisão narrativa do painel de especialistas AJR | Algoritmos de rastreamento em mamas densas.

24 Fev, 2022 | 15:35h

Screening Algorithms in Dense Breasts: AJR Expert Panel Narrative Review – American Journal of Roentgenology


Diretriz SMFM | Uso de analgesia e anestesia para procedimentos materno-fetais.

24 Fev, 2022 | 15:27h

Society for Maternal-Fetal Medicine Consult Series #59: The use of analgesia and anesthesia for maternal-fetal procedures – American Journal of Obstetrics and Gynecology


M-A | Cirurgia citorredutora secundária no câncer de ovário recorrente sensível à platina.

24 Fev, 2022 | 15:21h

Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Meta-Analysis – Journal of Clinical Oncology (link para o resumo – $ para o texto completo)

Comentário: Meta-Analysis Affirms Survival Benefit of Second Surgery in Ovarian Cancer — Mortality decreased with rising rates of complete, optimal cytoreduction at recurrence – MedPage Today (necessário cadastro gratuito)

Conteúdos relacionados:

RCT: Cytoreductive surgery for relapsed ovarian cancer.

Guide to enhanced recovery for cancer patients undergoing surgery: ERAS for Patients Undergoing Cytoreductive Surgery with or Without hyperthermic intraperitoneal chemotherapy.


OMS/UNICEF | Mais da metade dos pais e das gestantes são expostos à agressiva propaganda de fórmulas lácteas.

24 Fev, 2022 | 13:49h

More than half of parents and pregnant women exposed to aggressive formula milk marketing – WHO, UNICEF – World Health Organization

Comentário: Aggressive’ marketing of formula milk flouts code, warns WHO as it urges curbs – The Guardian

 

Comentário no Twitter

 


Amplo estudo baseado em registro nos EUA sugere que tratamentos para infertilidade são associados com riscos aumentados de complicações gestacionais e vasculares.

24 Fev, 2022 | 13:43h

In‐Hospital Complications in Pregnancies Conceived by Assisted Reproductive Technology – Journal of the American Heart Association

Comunicado de imprensa: Common infertility treatments may increase risks for pregnancy, vascular complications – American Heart Association

Comentário: Infertility treatments raise risk of heart and pregnancy complications, study finds – CNN


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.